Character Biosciences expands leadership, extends Series B to over $110M

Character Biosciences, a precision medicine company focused on polygenic diseases, has appointed four senior executives to its leadership team. Those additions are Robert Kim, M.D., MBA as Chief Medical Officer; Daniel Elgort, Ph.D. as Chief Data & Analytics Officer; Josh Buddle as Head of Clini…